Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ORTHOPEDIATRICS CORPKIDS · Entity 5338 | President of Scoliosis | March 15, 2026 | March 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ORTHOPEDIATRICS CORP
Report date March 15, 2026 · Filed March 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 196,168 |
Reported balance
After 2026-03-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-03-15 · Grant · Acquired 47,380 · Balance 196,168 |
| Common StockSEC Table I · non-derivative | Direct | 187,735 |
Reported balance
After 2026-03-16 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-03-16 · Sale · Disposed 8,433 · Balance 187,735 F1: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. F2: Includes restricted stock awards totaling 121,054 shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares.
F2: Includes restricted stock awards totaling 121,054 shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 16, 2026 Filed Mar 17, 2026 16:18 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 8,433 | $17.25 | $145,469.25 |
DisclosureSEC source: 0001425450-26-000020 · wk-form4_1773778682.xml · nonDerivative · entry 2 Odle Gregory A · CIK 0001719088 · President of Scoliosis 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,735 F1 · shares: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. F2 · balance_after: Includes restricted stock awards totaling 121,054 shares. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 16:18 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 47,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-26-000020 · wk-form4_1773778682.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · President of Scoliosis 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 196,168 Read SEC document |
| March 18, 2025 Filed Mar 18, 2025 14:44 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 5,359 | $24.86 | $133,224.74 |
DisclosureSEC source: 0001425450-25-000021 · wk-form4_1742323460.xml · nonDerivative · entry 2 Odle Gregory A · CIK 0001719088 · President of Scoliosis 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,788 F1 · shares: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. F2 · balance_after: Includes restricted stock awards totaling 93,291 shares. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 14:44 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 38,773 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-25-000021 · wk-form4_1742323460.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · President of Scoliosis 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,147 Read SEC document |
| June 11, 2024 Filed Jun 11, 2024 16:18 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 34,901 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-24-000068 · wk-form4_1718137097.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · President of Scoliosis 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,374 F1 · balance_after: Includes restricted stock awards totaling 66,882 shares. Read SEC document |
| March 11, 2024 Filed Mar 12, 2024 08:43 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 2,768 | $27.59 | $76,369.12 |
DisclosureSEC source: 0001425450-24-000023 · wk-form4_1710247408.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · President of Scoliosis 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,473 F1 · shares: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. F2 · balance_after: Includes restricted stock awards totaling 31,981 shares. Read SEC document |
| April 27, 2023 Filed Apr 28, 2023 09:00 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 3,333 | $50.10 | $166,969.30 |
DisclosureSEC source: 0001425450-23-000056 · wf-form4_168268679480793.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · President of Scoliosis 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 83,241 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · balance_after: Includes restricted stock awards totaling 37,910 shares. Read SEC document |
| April 25, 2023 Filed Apr 26, 2023 16:05 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 828 | $50.02 | $41,419.62 |
DisclosureSEC source: 0001425450-23-000054 · wf-form4_168253953538722.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · President of Scoliosis 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,574 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · balance_after: Includes restricted stock awards totaling 37,910 shares. Read SEC document |
| April 21, 2023 Filed Apr 24, 2023 16:23 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 644 | $50.02 | $32,211.91 |
DisclosureSEC source: 0001425450-23-000052 · wf-form4_168236778360389.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · President of Scoliosis 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,402 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · balance_after: Includes restricted stock awards totaling 37,910 shares. Read SEC document |
| March 15, 2023 Filed Mar 15, 2023 16:31 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 19,617 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-23-000048 · wf-form4_167891225258569.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · President of Scoliosis 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,046 F1 · balance_after: Includes restricted stock awards totaling 37,910 shares. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 09:15 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 3,421 | $44.03 | $150,618.42 |
DisclosureSEC source: 0001425450-23-000032 · wf-form4_167819850578407.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,429 F1 · shares: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. F2 · balance_after: Includes restricted stock awards totaling 18,293 shares. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 08:07 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 1,195 | $50.00 | $59,753.59 |
DisclosureSEC source: 0001425450-23-000016 · wf-form4_167542962959791.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,850 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · balance_after: Includes restricted stock awards totaling 25,830 shares. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 08:16 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 80 | $47.00 | $3,760.00 |
DisclosureSEC source: 0001425450-23-000014 · wf-form4_167456617398289.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,045 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · balance_after: Includes restricted stock awards totaling 25,830 shares. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 08:10 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 1,771 | $45.00 | $79,695.00 |
DisclosureSEC source: 0001425450-23-000012 · wf-form4_167396101744810.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,125 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · balance_after: Includes restricted stock awards totaling 25,830 shares. Read SEC document |
| January 09, 2023 Filed Jan 10, 2023 11:53 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 229 | $45.04 | $10,315.01 |
DisclosureSEC source: 0001425450-23-000010 · wf-form4_167336962174008.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,896 F1 · shares: Shares sold pursuant to a 10b5-1 plan. F2 · balance_after: Includes restricted stock awards totaling 25,830 shares. Read SEC document |
| March 15, 2022 Filed Mar 16, 2022 10:07 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 12,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-22-000040 · wf-form4_164743964241478.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,125 F1 · balance_after: Includes restricted stock awards totaling 25,830 shares. Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 14:24 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 4,108 | $57.55 | $236,415.40 |
DisclosureSEC source: 0001425450-22-000021 · wf-form4_164633543060244.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,761 F1 · shares: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. F2 · balance_after: Includes restricted stock awards totaling 13,466 shares. Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 11:37 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | Exercise / conversionStock Option (Right to Buy) · Derivative | 402 | $30.97 Strike: $30.97 | $12,449.94 |
DisclosureSEC source: 0001425450-21-000108 · wf-form4_162800501149107.xml · derivative · entry 2 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 402 shares Expires 2021-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. Read SEC document |
| August 02, 2021 Filed Aug 3, 2021 11:37 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | Exercise / conversionCommon Stock | 402 | $30.97 | $12,449.94 |
DisclosureSEC source: 0001425450-21-000108 · wf-form4_162800501149107.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,869 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes restricted stock awards totaling 22,981 shares. Read SEC document |
| May 03, 2021 Filed May 4, 2021 14:41 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 3,750 | $60.20 | $225,750.00 |
DisclosureSEC source: 0001425450-21-000065 · wf-form4_162015366814229.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,467 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 11:03 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 5,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-21-000039 · wf-form4_161478739264067.xml · nonDerivative · entry 2 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,217 F2 · balance_after: Includes restricted stock awards totaling 22,981 shares. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 11:03 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 8,193 | $55.88 | $457,824.84 |
DisclosureSEC source: 0001425450-21-000039 · wf-form4_161478739264067.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,288 F1 · shares: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. Read SEC document |
| February 19, 2021 Filed Feb 22, 2021 12:56 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 3,750 | $56.50 | $211,875.00 |
DisclosureSEC source: 0001425450-21-000027 · wf-form4_161401658848293.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,481 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| January 27, 2021 Filed Jan 28, 2021 10:18 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 3,750 | $51.63 | $193,612.50 |
DisclosureSEC source: 0001425450-21-000013 · wf-form4_161184707115249.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,231 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| December 23, 2020 Filed Dec 28, 2020 11:03 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 3,750 | $46.19 | $173,212.50 |
DisclosureSEC source: 0001425450-20-000126 · wf-form4_160917140986552.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,981 F1 · shares: Shares sold pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| May 21, 2020 Filed May 21, 2020 16:28 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | Exercise / conversionStock Option (Right to Buy) · Derivative | 402 | $30.97 Strike: $30.97 | $12,449.94 |
DisclosureSEC source: 0001425450-20-000049 · wf-form4_159009287584445.xml · derivative · entry 6 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 402 shares Expires 2020-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. Read SEC document |
| May 21, 2020 Filed May 21, 2020 16:28 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,040 | $30.97 Strike: $30.97 | $248,998.80 |
DisclosureSEC source: 0001425450-20-000049 · wf-form4_159009287584445.xml · derivative · entry 5 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,040 shares Expires 2020-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. Read SEC document |
| May 21, 2020 Filed May 21, 2020 16:28 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 402 | $46.33 | $18,624.66 |
DisclosureSEC source: 0001425450-20-000049 · wf-form4_159009287584445.xml · nonDerivative · entry 4 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,731 Read SEC document |
| May 21, 2020 Filed May 21, 2020 16:28 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 8,040 | $45.90 | $369,036.00 |
DisclosureSEC source: 0001425450-20-000049 · wf-form4_159009287584445.xml · nonDerivative · entry 3 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,133 Read SEC document |
| May 21, 2020 Filed May 21, 2020 16:28 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | Exercise / conversionCommon Stock | 402 | $30.97 | $12,449.94 |
DisclosureSEC source: 0001425450-20-000049 · wf-form4_159009287584445.xml · nonDerivative · entry 2 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,173 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2020 Filed May 21, 2020 16:28 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | Exercise / conversionCommon Stock | 8,040 | $30.97 | $248,998.80 |
DisclosureSEC source: 0001425450-20-000049 · wf-form4_159009287584445.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,771 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2020 Filed Mar 4, 2020 14:43 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 7,537 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-20-000014 · wf-form4_158335101956604.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,731 F1 · balance_after: Includes restricted stock awards totaling 36,052 shares. Read SEC document |
| December 13, 2019 Filed Dec 13, 2019 13:22 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 15,000 | $34.31 | $514,650.00 |
DisclosureSEC source: 0001425450-19-000105 · wf-form4_157626131354643.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,194 F1 · kind: Shares sold in an underwritten public offering in which the Reporting Person was a selling stockholder. F2 · balance_after: Includes restricted stock awards totaling 28,515 shares. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 09:19 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 9,515 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-19-000020 · wf-form4_155144998227499.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,194 F1 · balance_after: Includes restricted stock awards totaling 28,515 shares. Read SEC document |
| April 13, 2018 Filed Apr 16, 2018 15:32 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | SaleCommon Stock | 33,161 | $17.92 | $594,245.12 |
DisclosureSEC source: 0001425450-18-000054 · wf-form4_152390712454404.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,679 F1 · shares: Shares sold to satisfy tax withholding obligations upon vesting of restricted shares. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 15:39 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 19,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001425450-18-000028 · wf-form4_151993676197740.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,840 F1 · balance_after: Includes restricted stock awards totaling 94,280 shares. Read SEC document |
| October 16, 2017 Filed Oct 16, 2017 18:03 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | Tax withholdingCommon Stock | 14,773 | $13.00 | $192,049.00 |
DisclosureSEC source: 0001144204-17-052683 · tv477016_4.xml · nonDerivative · entry 2 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,840 F2 · shares: Represents shares delivered to the Issuer to satisfy tax withholdings in connection with the lapse of restrictions on 32.117 shares of restricted common stock. Read SEC document |
| October 16, 2017 Filed Oct 16, 2017 18:03 UTC | ORTHOPEDIATRICS CORP KIDS · Entity 5338 | GrantCommon Stock | 11,725 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-052683 · tv477016_4.xml · nonDerivative · entry 1 Odle Gregory A · CIK 0001719088 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,613 F1 · shares: Represents shares of restricted stock granted pursuant to the Issuer's 2017 Incentive Award Plan. These shares will vest in full on the six month anniversary of the grant date (subject to the reporting person's continued service through such date); provided, however, that these shares will vest in full if the reporting person's employment is terminated by reason of death or disability or without "cause," or if the reporting person terminates his employment for "good reason" (each as defined in the reporting person's employment agreement). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.